Boston Scientific Payment to net share settle employee equity awards increased by 2733.3% to $85.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 28.0%, from $118.00M to $85.00M. Over 4 years (FY 2021 to FY 2025), Payment to net share settle employee equity awards shows an upward trend with a 27.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher payments correlate with increased employee equity vesting and potentially higher stock price performance.
Cash paid by the company to satisfy tax withholding obligations when employees exercise equity awards, where the company...
Standard for companies with significant stock-based compensation programs.
financing_paymenttonetsharesettleemployeeequityawards| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $2.00M | $46.00M | $1.00M | $2.00M | $4.00M | $50.00M | $2.00M | $2.00M | $2.00M | $78.00M | $2.00M | $3.00M | $4.00M | $118.00M | $5.00M | $5.00M | $3.00M | $85.00M |
| QoQ Change | — | +0.0% | +100.0% | >999% | -97.8% | +100.0% | +100.0% | >999% | -96.0% | +0.0% | +0.0% | >999% | -97.4% | +50.0% | +33.3% | >999% | -95.8% | +0.0% | -40.0% | >999% |
| YoY Change | — | — | — | — | +0.0% | +100.0% | +100.0% | +8.7% | +100.0% | +0.0% | -50.0% | +56.0% | +0.0% | +50.0% | +100.0% | +51.3% | +150.0% | +66.7% | -25.0% | -28.0% |